Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial.

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

  • G.W. Albers - (Author)
  • R. Von Kummer - , Institute and Polyclinic of Diagnostic and Interventional Neuroradiology (Author)
  • T. Truelsen - (Author)
  • J.K. Jensen - (Author)
  • G.M. Ravn - (Author)
  • B.A. Grønning - (Author)
  • H. Chabriat - (Author)
  • K.C. Chang - (Author)
  • A.E. Davalos - (Author)
  • G.A. Ford - (Author)
  • J. Grotta - (Author)
  • M. Kaste - (Author)
  • L.H. Schwamm - (Author)
  • A. Shuaib - (Author)

Details

Original languageEnglish
Pages (from-to)575-584
Number of pages10
JournalThe Lancet Neurology
Publication statusPublished - 2015
Peer-reviewedYes

External IDs

Scopus 84929519483

Keywords